Benzylurea

CAS No. 538-32-9

Benzylurea( 1-Benzylurea | AI3-61350 | Benzylcarbamide | Benzylurea | N-Benzylurea | Phenylmethylurea | )

Catalog No. M27376 CAS No. 538-32-9

Benzylurea competitively inhibits dehydrogenase/cytokinin oxidase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Benzylurea
  • Note
    Research use only, not for human use.
  • Brief Description
    Benzylurea competitively inhibits dehydrogenase/cytokinin oxidase.
  • Description
    Benzylurea competitively inhibits dehydrogenase/cytokinin oxidase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1-Benzylurea | AI3-61350 | Benzylcarbamide | Benzylurea | N-Benzylurea | Phenylmethylurea |
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    538-32-9
  • Formula Weight
    150.181
  • Molecular Formula
    C8H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (665.87 mM)
  • SMILES
    NC(=O)NCc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamamuro D, Uchida R, Ohtawa M, Arima S, Futamura Y, Katane M, Homma H, Nagamitsu T, Osada H, Tomoda H. Synthesis and biological activity of 5-(4-methoxyphenyl)-oxazole derivatives. Bioorg Med Chem Lett. 2015 Jan 15;25(2):313-6. doi: 10.1016/j.bmcl.2014.11.042. Epub 2014 Nov 22. PubMed PMID: 25488842.
molnova catalog
related products
  • PDD00017273

    PDD00017273 is a radiosensitizing PARG) inhibitor with antitumor or activity for the study of epithelial ovaries.

  • 3,5-Dihydroxy-4-meth...

    3,5-Dihydroxy-4-methylbenzoic acid is a natural product.

  • PLH1215

    PLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.